Sorafenib as first line treatment for advanced liver cancer - are expiries
Title
Sorafenib as first line treatment for advanced liver cancer - are expiries
Identifier
/unibl/sci/idNaucniRad:25647
Type
See all items with this valueConference Paper
Date
Bibliographic Citation
Z. Gojković, S. Jungić, I. Rakita, Ž. Vranješ, R. Rašeta, G. Marić, M. Vještica, S. Mijatović, P. Dašić, M. Vižin, J. Rožić, Sorafenib as first line treatment for advanced liver cancer - are expiries, Annals of Oncology 2012; 23(4) iv57, 2012
presented at
Annals of Oncology
Is Part Of
See all items with this valueAnnals of Oncology 2012; 23(4) iv57
list of authors
Position: 7094 (36 views)